Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Investigating the Impact of Preimplantation Genetic Testing on the Incidence of Preeclampsia

EF 2023-24

Résumé
Infertility, defined as the failure to conceive after 12 months of unprotected sexual intercourse impacts 8-12% of reproductive-aged couples worldwide. In vitro fertilization(IVF) is an important medical resource for those struggling with infertility. IVF can be supplemented with preimplantation genetic testing(PGT) to determine embryo health prior to embryo transfer into the uterus. Recently, it has been identified that pregnancies resulting from IVF+PGT may be associated with serious pregnancy complications such as preeclampsia, a disorder that can result in damage to multiple organs as well as both maternal and fetal death. Therefore, investigating PGT’s impact on preeclampsia susceptibility is important in advancing the safety of reproductive techniques. This project aims to test the hypothesis that PGT effects the expression of genes involved in the development of preeclampsia. Gene expression will be compared between mouse IVF blastocysts that have received PGT treatment and IVF-Control blastocysts. Pathway analyses will be conducted on genes with differed expression in the PGT-exposed blastocysts to see if they have roles in placental dysfunction, a hallmark of preeclampsia. Furthermore, I will investigate the functional impact of transcriptionally-altered genes that are (1) identified in the PGT-exposed group and (2) identified as markers of placental dysfunction in literature. This will be assessed through gene-specific knockdown in a placental cell-line and subsequent assays to measure critical cellular functions that are characteristically altered in preeclampsia. The results of this study are crucial in identifying the effects of PGT techniques on pregnancy outcomes to further understand the impact of assisted reproduction on both maternal and fetal health.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506385
Name
Lemaire Melanie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Impact of Preimplantation Genetic Testing on the Incidence of Preeclampsia
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Model; Gene Expression; Gene Knockdown; In Vitro Fertilization; Mouse Model; Placental Dysfunction; Preeclampsia; Preimplantation Genetic Testing
Abstract
Infertility, defined as the failure to conceive after 12 months of unprotected sexual intercourse impacts 8-12% of reproductive-aged couples worldwide. In vitro fertilization(IVF) is an important medical resource for those struggling with infertility. IVF can be supplemented with preimplantation genetic testing(PGT) to determine embryo health prior to embryo transfer into the uterus. Recently, it has been identified that pregnancies resulting from IVF+PGT may be associated with serious pregnancy complications such as preeclampsia, a disorder that can result in damage to multiple organs as well as both maternal and fetal death. Therefore, investigating PGT’s impact on preeclampsia susceptibility is important in advancing the safety of reproductive techniques. This project aims to test the hypothesis that PGT effects the expression of genes involved in the development of preeclampsia. Gene expression will be compared between mouse IVF blastocysts that have received PGT treatment and IVF-Control blastocysts. Pathway analyses will be conducted on genes with differed expression in the PGT-exposed blastocysts to see if they have roles in placental dysfunction, a hallmark of preeclampsia. Furthermore, I will investigate the functional impact of transcriptionally-altered genes that are (1) identified in the PGT-exposed group and (2) identified as markers of placental dysfunction in literature. This will be assessed through gene-specific knockdown in a placental cell-line and subsequent assays to measure critical cellular functions that are characteristically altered in preeclampsia. The results of this study are crucial in identifying the effects of PGT techniques on pregnancy outcomes to further understand the impact of assisted reproduction on both maternal and fetal health.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lemaire, Melanie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~